Ken Fisher's position in Abbvie is currently worth $5.08 Million. That's 0.0% of their equity portfolio (427th largest holding). The first Abbvie trade was made in Q1 2013. Since then Ken Fisher bought shares fifteen more times and sold shares on 21 occasions. The stake costed the investor $1.75 Million, netting the investor a gain of 191% so far.
A new market report by The Insight Partners on the Laboratory Informatics Market has been released with reliable information and accurate forecasts for a bet...OpenPR, over 1 year ago
The winning e-Pharma Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of ...OpenPR, over 1 year ago